Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose Pharmacokinetics of Ceftaroline during Renal Replacement Therapy
2013-003914-42Phase 4Terminated
- Sponsor
- Medical University of Vienna
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ceftaroline fosamil in bacterial disease, sponsored by Medical University of Vienna. Primary endpoint: AUC of ceftaroline during renal replacement therapy. Started Sep 2013; status: terminated.
02
Drugs
ceftaroline fosamil
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2013-003914-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003914-42.